MNKD
NASDAQ
$3.98
Mannkind Corp (MNKD)
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutics for endocrine and orphan lung diseases in the United States. The company is headquartered in Westlake Village, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.59 (+90.70%)
Market Cap
$1.26B
Revenue 5Y CAGR
+40.31%
Free Cash Flow Yield
1.04%
Beta (5Y)
0.71
Price Chart
Valuation
Market Cap$1.26B
Forward P/E42.37
PEG4.39
P/S3.32
P/B187.85
Profitability
Total Revenue (TTM)$361M
Gross Profit (TTM)$273M
EBITDA$31M
Profit Margin-18.4%
Operating Margin-1.8%
EPS-$0.08
Financial Health
Debt-to-Equity-538.4%
Free Cash Flow Yield1.04%
Growth & Risk
EPS 5Y CAGR-21.18%
Revenue 5Y CAGR+40.31%
Beta (5Y)0.71
Sharpe Ratio0.36